Health & Science
Science-backed articles on psilocybin, magic truffles, dosage, safety, and research from Retraite Eveil in the Netherlands.
Tolerance to psilocybin: why redosing rarely works and how long to wait
Psilocybin produces profound effects at moderate doses, which leads some participants to wonder whether taking more during the same afternoon will extend or intensify the journey....
Read article →
Cross tolerance between psilocybin and other classic psychedelics
Cross tolerance means using one serotonergic psychedelic reduces responsiveness to another within a short window because they share primary receptor targets. Psilocybin, LSD, mesca...
Read article →
Are magic truffles vegan, organic, and allergen free: a factual checklist
Retreat menus and smart shop shelves increasingly carry vegan, organic, and allergen-free language beside magic truffle strain names. Fungi themselves are not animal products, yet...
Read article →
Patient selection in psilocybin trials: exclusions and rationale
Why psilocybin trials exclude many real-world patients, how criteria protect safety, and what generalizability limits mean.
Read article →
Lookalike mushrooms and poisoning risk: why foraging is dangerous
Fatal mushroom poisonings rarely involve psilocybin itself. They involve amatoxins and other lethal compounds in species that resemble liberty caps or wood loving Psilocybe on casu...
Read article →
Neuroplasticity after psilocybin: BDNF, synaptogenesis, and what we know in 2026
Neuroplasticity describes the brain's capacity to reorganize synaptic connections in response to experience, injury, or pharmacological signals. Psilocybin research revived interes...
Read article →
Psilocybin and eating disorders: why research is still preliminary
Hopkins and Imperial College pilot psilocybin for anorexia and related disorders under strict medical monitoring. Why evidence remains early stage and retreats are risky.
Read article →
Psilocybin metabolites in blood and urine: what toxicology screens detect
Toxicology laboratories detect psilocybin exposure by targeting psilocin and its glucuronide conjugates in blood and urine rather than the parent phosphate ester, which disappears...
Read article →
Psilocybin and OCD: early trials and open questions
Moreno 2006 pilot and Yale ongoing trials explore psilocybin assisted therapy for obsessive compulsive disorder. Early evidence, mechanisms, and caution explained.
Read article →
Alcohol before or after psilocybin: harm reduction perspective
Alcohol before or after psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
How to read truffle packaging labels: strain names and strength indicators
Dutch truffle pouches pack legal, tax, and pharmacological information into a few square centimeters of label space. Strain fantasy names, fresh gram weights, best before dates, an...
Read article →
Psilocybe species overview: which mushrooms contain psilocybin
The genus Psilocybe groups more than a hundred described species, yet only a handful appear on Dutch shop labels, cultivation forums, or clinical trial paperwork. Names like Mexica...
Read article →
Psychedelic first aid training: what RET and similar programs teach
Psychedelic first aid training. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
End of life anxiety and psilocybin: ethics, outcomes, and access
How clinical psilocybin research addresses existential distress in serious illness, and why ethics and access remain central.
Read article →
HPPD and psilocybin: prevalence, symptoms, and what the literature says
Hallucinogen persisting perception disorder, abbreviated HPPD, describes visual disturbances such as trails, halos, or static that continue after the acute psychedelic effects have...
Read article →
From Hofmann to today: milestones in psilocybin research timeline
Modern psilocybin headlines compress seven decades into a single breakthrough narrative, yet the research timeline includes prohibition eras, dormant decades, and renewed multicent...
Read article →
Tramadol, opioids, and psilocybin: serotonin syndrome awareness
Tramadol, opioids, and psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Truffle grading and quality control in legal Dutch supply chains
Legal magic truffles in the Netherlands pass through a supply chain that looks informal from a tourist sidewalk yet runs on repeatable cultivation, packaging, and retail habits. Gr...
Read article →
Absolute contraindications for psilocybin: psychiatric and medical list
Absolute contraindications for psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Set and setting: the science behind context and psychedelic outcomes
Set and setting entered psychedelic vocabulary in the mid twentieth century when clinicians noticed identical milligram doses produced radically different outcomes depending on moo...
Read article →
Fresh vs dried magic truffles: potency, weight, and storage science
Fresh magic truffles are mostly water. That single fact drives dosing confusion, shipping logistics, and every argument about whether drying increases power. This article explains...
Read article →
Imperial College London psilocybin research: key findings explained
Imperial College London hosts one of the world's leading psychedelic research centres. Its trials combine brain imaging with psychotherapy to study psilocybin for depression and re...
Read article →
Difficult trips: sitter roles, grounding techniques, and when to call medical help
Difficult trips. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Psilocybin vs MDMA vs ketamine: different tools, different mechanisms
Media coverage often lumps psychedelic therapy into a single headline, yet psilocybin, MDMA, and ketamine engage different receptor systems, produce different subjective profiles,...
Read article →
Psilocybin for tobacco cessation: Matthew Johnson research in plain language
Matthew Johnson at Johns Hopkins published influential psilocybin smoking cessation trials with high verified abstinence rates. This article explains methods, follow up, and limits...
Read article →
Johns Hopkins psilocybin studies: what changed between 2006 and today
Johns Hopkins University reopened modern psilocybin science in 2006 and now runs one of the world's largest clinical programs. This timeline explains landmark studies and what they...
Read article →
Pregnancy, breastfeeding, and psilocybin: absence of safety data
Pregnancy, breastfeeding, and psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
How magic truffles are cultivated in the Netherlands: process without promotion
Licensed Dutch growers supply most of the psilocybin sclerotia sold legally in Europe. Their workflow looks more like controlled food fermentation than a kitchen grow kit: sterile...
Read article →
Psilocybin and the gut: emerging research on the microbiome connection
Interest in gut brain signaling has expanded from irritable bowel psychiatry clinics into psychedelic pharmacology as researchers ask whether serotonin active compounds reshape mic...
Read article →
Survey data on self reported mental health changes after retreats
How post-retreat surveys are collected, why selection bias limits inference, and what they cannot prove about clinical efficacy.
Read article →
Psilocybin mushrooms vs truffles: bioavailability and onset time differences
Travelers often ask whether magic mushrooms and magic truffles feel different because of chemistry or because of how products are sold in Amsterdam. Both forms deliver psilocybin,...
Read article →
Schizophrenia spectrum and psychedelics: why caution is standard
Schizophrenia spectrum and psychedelics. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
What is psilocybin: chemical structure, natural sources, and how the body converts it
Psilocybin occupies a distinctive place in pharmacology as a naturally occurring tryptamine alkaloid produced by more than two hundred species of fungi, including Psilocybe mushroo...
Read article →
Cannabis plus psilocybin: intensification risks at retreats
Cannabis plus psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Psilocybin and anxiety in life threatening illness: Grob and Ross studies
Grob 2011 and Ross 2016 NYU Langone trials tested psilocybin assisted therapy for cancer related anxiety and existential distress. This article summarizes outcomes, limits, and how...
Read article →
Psilocybin content by strain: Tampanensis, Mexicana, Atlantis, and what labels mean
Shop menus list Tampanensis, Mexicana, Atlantis, and a parade of fantasy names implying predictable psilocybin milligrams. Laboratory reality is messier: overlapping ranges, moistu...
Read article →
Psilocybin purity and adulterants: risks in unregulated markets vs legal truffles
Unregulated psychedelic markets sell dried mushrooms, powders, and tablets whose active ingredient identity is often unknown without laboratory testing. Legal Dutch sclerotia suppl...
Read article →
Adverse events in clinical psilocybin trials
How sponsors report adverse events in psilocybin trials, what serious events look like, and how denominators shape public understanding of risk.
Read article →
Environmental conditions for sclerotia formation: temperature, humidity, substrate
Sclerotia are not accidental lumps in a grow tray. They form when psilocybin-producing fungi interpret environmental stress as a signal to store nutrients underground rather than i...
Read article →
Heart conditions and psilocybin: blood pressure and arrhythmia considerations
Heart conditions and psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Therapeutic windows: why session length matters in clinical trials
Clinical teams speak about therapeutic windows when describing how long a psilocybin session remains pharmacologically active and psychologically workable before effects taper into...
Read article →
Psilocybin and sleep: what happens to sleep architecture after a session
Sleep complaints after psychedelic sessions are common in retreat surveys yet rarely measured with the same rigor as mood scales in depression trials. Polysomnography, the gold sta...
Read article →
Truffle shelf life: signs of spoilage and when not to consume
Fresh magic truffles are perishable biological material, not shelf-stable supplements. From the moment a grower harvests sclerotia until you open a vacuum bag, clock starts on mois...
Read article →
Lithium and psychedelics: a documented dangerous interaction
Lithium and psychedelics. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Psilocin explained: the active molecule behind psilocybin effects
Psilocin is the pharmacologically active metabolite formed when alkaline phosphatases cleave the phosphate group from psilocybin. Unlike the prodrug, psilocin bears a free hydroxyl...
Read article →
Identifying psilocybin mushrooms in the wild: safety warnings and legal risks
Autumn meadows and wood chip beds tempt visitors to pick wild psilocybin mushrooms after reading species lists online. The activity combines botanical difficulty, criminal risk, an...
Read article →
Mycelium vs sclerotium: the life cycle of psilocybin producing fungi
Psilocybin fungi express multiple body plans during one life cycle: microscopic spores, threadlike mycelium, above ground mushrooms, and underground sclerotia. Dutch law cares abou...
Read article →
Psilocybin for alcohol use disorder: NYU and related trials
Michael Bogenschutz led NYU trials including a 2022 JAMA Psychiatry randomized study of psilocybin assisted therapy for alcohol use disorder. Design, outcomes, and limits explained...
Read article →
Psilocybin and serotonin receptors: why the 5 HT2A receptor matters
Classic psychedelics including psilocybin produce their characteristic effects primarily through agonism at the serotonin 5-HT2A receptor, a G protein-coupled receptor enriched on...
Read article →
Psychedelic assisted therapy vs retreat model: structural differences
Clinical psychedelic-assisted therapy and group retreats share psilocybin but diverge sharply in regulation, staffing, and therapeutic intent.
Read article →
Psilocybin for treatment resistant depression: COMPASS Pathways and beyond
Treatment resistant depression affects millions who fail two or more antidepressant courses. COMPASS Pathways COMP360 trials and academic studies are testing whether psilocybin wit...
Read article →
Sexual boundaries during psychedelic experiences: consent and facilitation ethics
Sexual boundaries during psychedelic experiences. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Workplace drug testing in the Netherlands and psilocybin metabolites
Workplace drug testing in the Netherlands intersects awkwardly with truffle tolerance. Domestic law may tolerate personal psilocybin use in private settings, yet employers, especia...
Read article →
Default mode network and psilocybin: what brain imaging studies show
Functional brain imaging changed how researchers talk about psilocybin. Instead of treating psychedelic states as opaque subjective events, teams at Imperial College London, Johns...
Read article →
Psilocybin and PTSD: comparison with MDMA assisted therapy
MAPS Mitchell 2022 NEJM trial advanced MDMA assisted therapy for PTSD while psilocybin PTSD research remains earlier stage. Evidence, protocols, and safety compared.
Read article →
Synthetic psilocybin vs natural truffles: clinical and experiential differences
Hospital depression trials increasingly administer synthetic psilocybin capsules while Dutch smart shops sell psilocybin inside wet fungal sclerotia. Both routes deliver the same p...
Read article →
Bipolar disorder and psilocybin: mania risk and professional guidance
Bipolar disorder and psilocybin. Educational guide on risk, screening, and harm reduction for psilocybin contexts.
Read article →
Placebo, expectancy, and blinding in psilocybin trials
Why double-blind designs struggle with psilocybin, how expectancy shapes outcomes, and what readers should infer from trial statistics.
Read article →
Psilocybin vs LSD vs mescaline: pharmacology comparison for curious readers
Classic psychedelics share a family resemblance: altered perception, time distortion, and introspective depth after serotonergic receptor activation. Psilocybin, LSD, and mescaline...
Read article →
How long does psilocybin stay in your system: metabolism, half life, and detection windows
Psilocybin itself is largely absent from blood within hours because alkaline phosphatases rapidly convert it to psilocin, the analyte that best reflects acute exposure. Half-life e...
Read article →
Sclerotia explained: why truffles are not botanical truffles
Walk into a Dutch smart shop and you will see products labeled magic truffles. The word truffle evokes black Perigord fungi scraped from oak roots, yet what you are buying is somet...
Read article →
Psilocybin and the Hypnagogic Lamp: Synergies for Expanded States of Consciousness
Psilocybin and the hypnagogic lamp represent two powerful gateways into altered states of consciousness. One works through chemistry on serotonin receptors, the other through rhyth...
Read article →
Psychedelic Retreats and Personal Development: When Traditional Medicine Meets Modern Science!
Psychedelic retreats have seen remarkable growth in recent years. More and more people are turning to these guided experiences as a path to personal development, emotional healing,...
Read article →
Psychedelic Retreats: How They Help You Let Go of Control and Regain Clarity
In a world where control often seems to be the key to success, many people experience deep exhaustion from the constant effort of trying to manage everything. Work, relationships,...
Read article →
Studies and Testimonials: How Psilocybin Helps Combat Depression?
Depression affects millions of people around the world and represents one of the most significant challenges in mental health today. Despite advances in conventional treatments, ma...
Read article →
Psilocybin vs. Psilocine : Differences, effects, conversion, dosage, research, and safety
Hallucinogenic mushrooms (also known as psilocybin mushrooms, shrooms , or psilocybe mushrooms) have been used for centuries for spiritual, therapeutic, and recreational purposes....
Read article →
The Difference Between Magic Mushrooms and Magic Truffles: A Complete Guide
Discover why magic truffles are the ideal option for your legal psychedelic retreat in the Netherlands.In a world dominated by stress, anxiety, and the search for meaning, more and...
Read article →
Psilocybin Dosage Guidelines for Magic Truffles
Psilocybin, the active compound in magic truffles (sclerotia of certain psilocybin-containing fungi), can produce a range of psychological effects depending on the dose. Determinin...
Read article →